Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial.

Phytotherapy Research : PTR
Jestin V ThomasIllathu Madhavamenon Krishnakumar

Abstract

A 6-week, randomized, open-label, active-controlled clinical trial was conducted to evaluate the influence of a low-dose curcumagalactomannosides (CGM) (400 mg once daily) in OA subjects. The treatment was compared with a standard combination of 500 mg glucosamine hydrochloride (GLN) and 415 mg chondroitin sulphate (CHN), supplied as a single oral dose twice a day. Out of 84 subjects randomized, 72 subjects who have completed the study were evaluated for the safety and efficacy of the treatments at baseline and subsequent visits (day 28 and 42), by measuring walking performance, VAS, KPS, and WOMAC scores. CGM exhibited 47.02, 21.43, and 206% improvement in VAS, KPS, and walking performance, respectively, compared to the baseline. Similarly, there was 31.17, 32.93, 36.44, and 35% improvement in the pain, stiffness, physical function, and total WOMAC scores. CGM also caused a substantial reduction in the serum inflammatory marker levels. The results indicate that a short-term supplementation of a low dosage CGM exerted superior beneficial effects than a high-dosage CHN-GLN combination in alleviating the pain and symptoms of OA subjects. Further clinical trials of extended duration in a larger population is required to substantia...Continue Reading

References

Jun 3, 1999·The Surgical Clinics of North America·J Katz, R Melzack
Apr 5, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Nita Chainani-Wu
Dec 1, 1958·Annals of the Rheumatic Diseases·J H KELLGREN, J S LAWRENCE
Jan 11, 2005·Osteoarthritis and Cartilage·R ChristensenH Bliddal
Apr 18, 2008·The Journal of Pharmacology and Experimental Therapeutics·Aynun N BegumSally A Frautschy
Jul 1, 2009·Arthritis and Rheumatism·Gregory LivshitsTim D Spector
Oct 20, 2009·Osteoarthritis and Cartilage·Y HenrotinA Mobasheri
Mar 6, 2012·Bone·Carla R Scanzello, Steven R Goldring
Aug 10, 2012·The British Journal of Nutrition·Jürgen ZentekWilfried Vahjen
Dec 4, 2012·Arthritis Care & Research·Elena LosinaJeffrey N Katz
Feb 1, 2012·Asian Pacific Journal of Tropical Biomedicine·Evan Prince SabinaMahaboobkhan Rasool
Jul 23, 2013·BMC Medical Informatics and Decision Making·Dominik PéusSilvia Hofer
May 24, 2014·Phytotherapy Research : PTR·Yunes PanahiAmirhossein Sahebkar
May 29, 2014·BioMed Research International·Parveen KumarShrirang Jamadagni
Oct 14, 2014·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Yasuaki NakagawaTakashi Nakamura
May 28, 2015·Bioorganic & Medicinal Chemistry·Sergey S Laev, Nariman F Salakhutdinov
Mar 5, 2016·Journal of Drug Targeting·Weidong LiuGuangxi Zhai
Jul 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Giuseppe DerosaAmirhossein Sahebkar
Feb 27, 2018·Phytotherapy Research : PTR·Vahid SoleimaniHossein Hosseinzadeh
May 19, 2018·Critical Reviews in Eukaryotic Gene Expression·Muhammad Usman AkbarMuhammad Ibrahim
Jun 15, 2019·Arthritis Research & Therapy·Collin A HaradenVirginia Byers Kraus
Sep 11, 2019·Nutrients·Michele Dei Cas, Riccardo Ghidoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.